AGEN Agenus, Inc Total Debt to Capital
Agenus (AGEN) minimizes losses from individual trial failures through a broad pool of partnerships with global corporations. The price action of the total debt-to-equity ratio, which currently stands at 0.00, complements revenue data from the development of cancer immunotherapy agents. The business is currently undergoing rigorous cost optimization and a strategic pivot toward the sale of its core oncology drugs.
Analytical breakdowns and data insights for company Agenus, Inc (AGEN)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:AGEN - Agenus Inc.
The financial stability of Agenus (AGEN) depends on the balance between R&D expenditures and external financing. An analysis of the company's debt-to-equity ratio allows for an assessment of the business's reliance on borrowed funds. This metric is calculated as the sum of all liabilities divided by shareholders' equity. For a biotech firm, this is critical: licensing payments from partners must cover the debt load. An optimal leverage level confirms investment attractiveness and the fair value of assets.
Main competitors
Debt to Equity argenx ARGX|Aggregate Debt to Equity BioNTech Inc.|Abivax SA (ABVX) - Total Debt to Capital|All Debt to Shareholders' Equity Ratio ADMA Corp (ADMA)|Total Debt to Capital PTGX (Protagonist Therapeutics)|immunovant.com - Total Debt to Capital|Debt to Equity Kiniksa (KNSA)|GRFS: All Debt to Shareholders' Equity Ratio|ADPT (Adaptive Biotechnologies Corp) - Debt to Equity|Celldex Corp (CLDX) - Total Debt to Equity Ratio|AUPH (Aurinia Pharmaceuticals) - Total Debt to Capital|Total Debt to Capital biocryst.com (BCRX)|Vera Therapeutics (VERA) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio Dianthus Therapeutics Inc (DNTH)|Total Debt to Capital PHVS|AbCellera - Total Debt to Capital Coefficient|TRML: Debt to Equity|PGEN: Total Debt to Equity Ratio|PHAR (Pharming Group) - Debt to Equity|Total Debt to Equity Ratio Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Total Debt to Equity Ratio|Total Debt to Capital ZBIO|Debt to Equity Immunome, Inc. IMNM|Debt to Equity Ratio gossamerbio.com (GOSS)|KALV: Total Debt to Capital|Debt to Capital Septerna, Inc. SEPN|Pieris Pharmaceuticals Inc - Total Debt to Capital|SVRA - Total Debt to Capital|Total Debt to Capital RIGL (Rigel Pharmaceuticals)|anaptysbio.com (ANAB) - Debt to Capital Ratio|Total Debt to Capital ATXS (Astria Therapeutics, Inc.)|Debt to Capital ENGN|Debt to Equity RAPT Therapeutics, Inc. RAPT|Debt to Equity Ratio aerovatetx.com JBIO|Total Debt to Equity Ratio ACRS (Aclaris Therapeutics)|kyvernatx.com - Total Debt to Capital|Debt to Equity TLSA (Tiziana Life Sciences Ltd)|CABA - Total Debt to Capital Coefficient|VTYX: Total Debt to Capital|Theratechnologies, Inc (THTX) - Total Debt to Capital|Avalo Therapeutics, Inc - Total Debt to Capital|Debt to Capital Ratio eledon.com|Climb Bio - Total Debt to Capital|Debt to Capital ZURA (Zura Bio Ltd)|ATYR - Debt to Equity|Adagene Inc - Debt to Equity Ratio|Debt to Equity Ikena Oncology, Inc.|STTK - Aggregate Debt to Equity|Total Debt to Capital equilliumbio.com EQ|Connect Biopharma Holdings Limited (CNTB) - All Debt to Shareholders' Equity Ratio|IMUX (Immunic Therapeutics) - Total Debt to Capital|Total Debt to Capital ATRA|InflaRx N.V. (IFRX) - Debt to Equity|All Debt to Shareholders' Equity Ratio XFOR (x4pharma.com)|Adicet Bio, Inc. - Debt to Equity|Total Debt to Equity Ratio Celularity Inc CELU|INmune Bio Corp - Total Debt to Capital|Barinthus Biotherapeutics Corp (BRNS) - Total Debt to Capital|Total Debt to Equity Ratio Kezar Life Sciences KZR|sabbiotherapeutics.com (SABS) - All Debt to Shareholders' Equity Ratio|AKTX: Total Debt to Capital|Total Debt to Capital Coefficient ENLV|Debt to Equity QTTB (Q32 Bio Inc.)|Total Debt to Equity Ratio GOVX (GeoVax Corp)|Edesa Biotech, Inc. - Debt to Equity|IBIO - Total Debt to Equity Ratio|Carisma Tx - Total Debt to Equity Ratio|XTLB: Total Debt to Capital|Debt to Equity boltbio.com|HCW Biologics (HCWB) - Debt to Equity Ratio|Total Debt to Capital APVO (Aptevo Therapeutics, Inc.)|Debt to Capital AIM ImmunoTech, Inc.|Total Debt to Capital ADTX|Total Debt to Capital GRI Bio Inc (GRI)|XRTX (XORTX) - Total Debt to Capital|Debt to Capital Ratio Vyome Therapeutics HIND|REVB (Revelation Biosciences) - Total Debt to Capital|INDP: Debt to Capital|Debt to Equity Scinai Immunotherapeutics Ltd.|Debt to Equity Ratio CalciMedica|AFMD (Affimed NV) - Total Debt to Equity Ratio|Total Debt to Capital ALLK|HOOK (HOOKIPA Pharma Inc.) - Debt to Equity|Total Debt to Capital Coefficient igmbio.com (IGMS)|Total Debt to Capital ITOS (iTeos Therapeutics, Inc.)|Total Debt to Capital Ocean Biomedical Inc OCEA|Total Debt to Capital TCBP|THRD - Debt to Capital Ratio